Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated potassium channel subfamily C member 3 (KCNC3 / Kv3.3) is a protein that forms part of the voltage-gated potassium channels, crucial for regulating the electrical excitability of cells by allowing selective passage of potassium ions across cell membranes in response to changes in membrane potential. Kv3.3 is particularly important for enabling rapid repolarization of action potentials in neurons, allowing neurons—especially cerebellar Purkinje cells—to fire at high frequencies. Mutations or dysfunctions in KCNC3 have been associated with neurological disorders such as spinocerebellar ataxia type 13 (SCA13).
Modulation of neuronal excitability by regulating potassium ion flow across neuronal membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated potassium channel subfamily C member 3 (Kv3.3).